-
1
-
-
69149086060
-
Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine
-
Beigel, J. H., J. Voell, C. Y. Huang, P. D. Burbelo, and H. C. Lane. 2009. Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. J. Infect. Dis. 200:501-509.
-
(2009)
J. Infect. Dis.
, vol.200
, pp. 501-509
-
-
Beigel, J.H.1
Voell, J.2
Huang, C.Y.3
Burbelo, P.D.4
Lane, H.C.5
-
2
-
-
40549088240
-
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
-
Bernstein, D. I., et al. 2008. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J. Infect. Dis. 197: 667-675.
-
(2008)
J. Infect. Dis.
, vol.197
, pp. 667-675
-
-
Bernstein, D.I.1
-
3
-
-
77956837160
-
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets
-
Bosch, B. J., et al. 2010. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J. Virol. 84:10366-10374.
-
(2010)
J. Virol.
, vol.84
, pp. 10366-10374
-
-
Bosch, B.J.1
-
4
-
-
42949157327
-
Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle
-
Bright, R. A., et al. 2008. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 3:e1501.
-
(2008)
PLoS One
, vol.3
-
-
Bright, R.A.1
-
5
-
-
34247139232
-
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin
-
Bright, R. A., et al. 2007. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25:3871-3878.
-
(2007)
Vaccine
, vol.25
, pp. 3871-3878
-
-
Bright, R.A.1
-
6
-
-
79952468781
-
The humoral response to Gardasil(R) over four years as defined by Total IgG and competitive Luminex immunoassay
-
Brown, D. R., et al. 2011. The humoral response to Gardasil(R) over four years as defined by Total IgG and competitive Luminex immunoassay. Hum. Vaccin. 7:230-238.
-
(2011)
Hum. Vaccin.
, vol.7
, pp. 230-238
-
-
Brown, D.R.1
-
7
-
-
0026662909
-
Structural basis of antigenic variation: studies of influenza virus neuraminidase
-
Colman, P. M. 1992. Structural basis of antigenic variation: studies of influenza virus neuraminidase. Immunol. Cell Biol. 70:209-214.
-
(1992)
Immunol. Cell Biol.
, vol.70
, pp. 209-214
-
-
Colman, P.M.1
-
8
-
-
0033522494
-
Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes
-
Crawford, J., et al. 1999. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17:2265-2274.
-
(1999)
Vaccine
, vol.17
, pp. 2265-2274
-
-
Crawford, J.1
-
9
-
-
77953710988
-
Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
-
Deschuyteneer, M., et al. 2010. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine. Hum. Vaccin. 6:407-419.
-
(2010)
Hum. Vaccin.
, vol.6
, pp. 407-419
-
-
Deschuyteneer, M.1
-
10
-
-
47849101644
-
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007
-
Eichelberger, M., et al. 2008. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 26:4299-4303.
-
(2008)
Vaccine
, vol.26
, pp. 4299-4303
-
-
Eichelberger, M.1
-
11
-
-
53649110260
-
Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
-
Eichelberger, M. C., A. Hassantoufighi, M. Wu, and M. Li. 2008. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. Virol. J. 5:109.
-
(2008)
Virol. J.
, vol.5
, pp. 109
-
-
Eichelberger, M.C.1
Hassantoufighi, A.2
Wu, M.3
Li, M.4
-
12
-
-
42949111564
-
Human infection with highly pathogenic H5N1 influenza virus
-
Gambotto, A., S. M. Barratt-Boyes, M. D. de Jong, G. Neumann, and Y. Kawaoka. 2008. Human infection with highly pathogenic H5N1 influenza virus. Lancet 371:1464-1475.
-
(2008)
Lancet
, vol.371
, pp. 1464-1475
-
-
Gambotto, A.1
Barratt-Boyes, S.M.2
de Jong, M.D.3
Neumann, G.4
Kawaoka, Y.5
-
13
-
-
79954594723
-
Influenza virus-like particles as a new tool for vaccine immunogenicity testing: validation of a neuraminidase neutralizing antibody assay
-
Gavrilov, V., et al. 2011. Influenza virus-like particles as a new tool for vaccine immunogenicity testing: validation of a neuraminidase neutralizing antibody assay. J. Virol. Methods 173:364-373.
-
(2011)
J. Virol. Methods
, vol.173
, pp. 364-373
-
-
Gavrilov, V.1
-
14
-
-
0032735685
-
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
-
Katz, J. M., et al. 1999. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J. Infect. Dis. 180:1763-1770.
-
(1999)
J. Infect. Dis.
, vol.180
, pp. 1763-1770
-
-
Katz, J.M.1
-
15
-
-
79951812752
-
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
-
Kemp, T. J., et al. 2011. HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine 29:2011-2014.
-
(2011)
Vaccine
, vol.29
, pp. 2011-2014
-
-
Kemp, T.J.1
-
16
-
-
77953009742
-
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus
-
Khurana, S., et al. 2010. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci. Transl. Med. 2:15ra5.
-
(2010)
Sci. Transl. Med.
, vol.2
-
-
Khurana, S.1
-
17
-
-
79960563634
-
Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines
-
Khurana, S., et al. 2011. Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. Vaccine 29:5657-5665.
-
(2011)
Vaccine
, vol.29
, pp. 5657-5665
-
-
Khurana, S.1
-
18
-
-
66149149791
-
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets
-
Khurana, S., et al. 2009. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 6:e1000049.
-
(2009)
PLoS Med
, vol.6
-
-
Khurana, S.1
-
19
-
-
79957840765
-
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines
-
Khurana, S., et al. 2011. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci. Transl. Med. 3:85ra48.
-
(2011)
Sci. Transl. Med.
, vol.3
-
-
Khurana, S.1
-
20
-
-
78651396311
-
Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and crossprotective immunity in ferrets
-
Khurana, S., et al. 2011. Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and crossprotective immunity in ferrets. J. Virol. 85:1246-1256.
-
(2011)
J. Virol.
, vol.85
, pp. 1246-1256
-
-
Khurana, S.1
-
21
-
-
77955411860
-
Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus
-
Khurana, S., et al. 2010. Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. PLoS One 5:e11548.
-
(2010)
PLoS One
, vol.5
-
-
Khurana, S.1
-
22
-
-
0029837041
-
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults
-
Lakey, D. L., et al. 1996. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J. Infect. Dis. 174:838-841.
-
(1996)
J. Infect. Dis.
, vol.174
, pp. 838-841
-
-
Lakey, D.L.1
-
23
-
-
78650981716
-
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza
-
Landry, N., et al. 2010. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 5:e15559.
-
(2010)
PLoS One
, vol.5
-
-
Landry, N.1
-
24
-
-
77951883155
-
Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults
-
Langley, J. M., et al. 2010. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. J. Infect. Dis. 201:1644-1653.
-
(2010)
J. Infect. Dis.
, vol.201
, pp. 1644-1653
-
-
Langley, J.M.1
-
25
-
-
0034972583
-
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins
-
Latham, T., and J. M. Galarza. 2001. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J. Virol. 75:6154-6165.
-
(2001)
J. Virol.
, vol.75
, pp. 6154-6165
-
-
Latham, T.1
Galarza, J.M.2
-
26
-
-
33646349451
-
Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection
-
Li, X., et al. 2006. Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection. DNA Cell Biol. 25:197-205.
-
(2006)
DNA Cell Biol
, vol.25
, pp. 197-205
-
-
Li, X.1
-
27
-
-
80053606312
-
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
-
2 August doi: 10.1016/j.vaccine.2001.07.099
-
Lopez-Macias, C., et al. 2 August 2011. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico. Vaccine. doi: 10.1016/j.vaccine.2001.07.099.
-
(2011)
Vaccine
-
-
Lopez-Macias, C.1
-
28
-
-
79952228974
-
A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells
-
Lu, H., et al. 2011. A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells. PLoS One 6:e17297.
-
(2011)
PLoS One
, vol.6
-
-
Lu, H.1
-
29
-
-
0025370971
-
Rotavirus proteins VP7, NS28, and VP4 form oligomeric structures
-
Maass, D. R., and P. H. Atkinson. 1990. Rotavirus proteins VP7, NS28, and VP4 form oligomeric structures. J. Virol. 64:2632-2641.
-
(1990)
J. Virol.
, vol.64
, pp. 2632-2641
-
-
Maass, D.R.1
Atkinson, P.H.2
-
30
-
-
51349140305
-
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses
-
Mahmood, K., et al. 2008. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine 26:5393-5399.
-
(2008)
Vaccine
, vol.26
, pp. 5393-5399
-
-
Mahmood, K.1
-
31
-
-
79551518897
-
Characteristics of the earliest cross-neutralizing antibody response to HIV-1
-
Mikell, I., et al. 2011. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog. 7:e1001251.
-
(2011)
PLoS Pathog
, vol.7
-
-
Mikell, I.1
-
32
-
-
0042825878
-
Virus-like particles as immunogens
-
Noad, R., and P. Roy. 2003. Virus-like particles as immunogens. Trends Microbiol. 11:438-444.
-
(2003)
Trends Microbiol
, vol.11
, pp. 438-444
-
-
Noad, R.1
Roy, P.2
-
33
-
-
64549129973
-
Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure
-
Noah, D. L., H. Hill, D. Hines, E. L. White, and M. C. Wolff. 2009. Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin. Vaccine Immunol. 16:558-566.
-
(2009)
Clin. Vaccine Immunol.
, vol.16
, pp. 558-566
-
-
Noah, D.L.1
Hill, H.2
Hines, D.3
White, E.L.4
Wolff, M.C.5
-
34
-
-
77954982131
-
Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternaryspecific antibodies that effectively neutralize HIV-1
-
Pancera, M., et al. 2010. Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternaryspecific antibodies that effectively neutralize HIV-1. J. Virol. 84:8098-8110.
-
(2010)
J. Virol.
, vol.84
, pp. 8098-8110
-
-
Pancera, M.1
-
35
-
-
0018421350
-
Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate
-
Potier, M., L. Mameli, M. Belisle, L. Dallaire, and S. B. Melancon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
-
(1979)
Anal. Biochem.
, vol.94
, pp. 287-296
-
-
Potier, M.1
Mameli, L.2
Belisle, M.3
Dallaire, L.4
Melancon, S.B.5
-
36
-
-
77954217881
-
Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus
-
Pushko, P., et al. 2010. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Vaccine 28:4771-4776.
-
(2010)
Vaccine
, vol.28
, pp. 4771-4776
-
-
Pushko, P.1
-
37
-
-
27944456097
-
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice
-
Pushko, P., et al. 2005. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 23:5751-5759.
-
(2005)
Vaccine
, vol.23
, pp. 5751-5759
-
-
Pushko, P.1
-
38
-
-
77957936654
-
Virus-like particles in vaccine development
-
Roldao, A., M. C. Mellado, L. R. Castilho, M. J. Carrondo, and P. M. Alves. 2010. Virus-like particles in vaccine development. Expert Rev. Vaccines 9:1149-1176.
-
(2010)
Expert Rev. Vaccines
, vol.9
, pp. 1149-1176
-
-
Roldao, A.1
Mellado, M.C.2
Castilho, L.R.3
Carrondo, M.J.4
Alves, P.M.5
-
39
-
-
63849131879
-
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
-
Scheid, J. F., et al. 2009. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458:636-640.
-
(2009)
Nature
, vol.458
, pp. 636-640
-
-
Scheid, J.F.1
-
40
-
-
34249669303
-
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
-
Simmons, C. P., et al. 2007. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 4:e178.
-
(2007)
PLoS Med
, vol.4
-
-
Simmons, C.P.1
-
41
-
-
41849090140
-
Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats
-
Straight, T. M., M. G. Ottolini, G. A. Prince, and M. C. Eichelberger. 2008. Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats. Virol. J. 5:44.
-
(2008)
Virol. J.
, vol.5
, pp. 44
-
-
Straight, T.M.1
Ottolini, M.G.2
Prince, G.A.3
Eichelberger, M.C.4
-
42
-
-
0029822596
-
Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults
-
Treanor, J. J., et al. 1996. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. J. Infect. Dis. 173:1467-1470.
-
(1996)
J. Infect. Dis.
, vol.173
, pp. 1467-1470
-
-
Treanor, J.J.1
-
43
-
-
33645399959
-
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
-
Treanor, J. J., J. D. Campbell, K. M. Zangwill, T. Rowe, and M. Wolff. 2006. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N. Engl. J. Med. 354:1343-1351.
-
(2006)
N. Engl. J. Med.
, vol.354
, pp. 1343-1351
-
-
Treanor, J.J.1
Campbell, J.D.2
Zangwill, K.M.3
Rowe, T.4
Wolff, M.5
-
44
-
-
33646067475
-
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults
-
Treanor, J. J., et al. 2006. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J. Infect. Dis. 193:1223-1228.
-
(2006)
J. Infect. Dis.
, vol.193
, pp. 1223-1228
-
-
Treanor, J.J.1
-
45
-
-
0035825607
-
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
-
Treanor, J. J., et al. 2001. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19:1732-1737.
-
(2001)
Vaccine
, vol.19
, pp. 1732-1737
-
-
Treanor, J.J.1
-
46
-
-
0026781840
-
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
-
Tulip, W. R., J. N. Varghese, W. G. Laver, R. G. Webster, and P. M. Colman. 1992. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. J. Mol. Biol. 227:122-148.
-
(1992)
J. Mol. Biol.
, vol.227
, pp. 122-148
-
-
Tulip, W.R.1
Varghese, J.N.2
Laver, W.G.3
Webster, R.G.4
Colman, P.M.5
-
47
-
-
0026668006
-
Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface
-
Tulip, W. R., J. N. Varghese, R. G. Webster, W. G. Laver, and P. M. Colman. 1992. Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface. J. Mol. Biol. 227:149-159.
-
(1992)
J. Mol. Biol.
, vol.227
, pp. 149-159
-
-
Tulip, W.R.1
Varghese, J.N.2
Webster, R.G.3
Laver, W.G.4
Colman, P.M.5
-
48
-
-
70349887757
-
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
-
Walker, L. M., et al. 2009. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285-289.
-
(2009)
Science
, vol.326
, pp. 285-289
-
-
Walker, L.M.1
-
49
-
-
32844456405
-
Expression and purification of an influenza hemagglutinin- one step closer to a recombinant protein-based influenza vaccine
-
Wang, K., et al. 2006. Expression and purification of an influenza hemagglutinin- one step closer to a recombinant protein-based influenza vaccine. Vaccine 24:2176-2185.
-
(2006)
Vaccine
, vol.24
, pp. 2176-2185
-
-
Wang, K.1
-
50
-
-
45749084541
-
Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus
-
Wei, C. J., et al. 2008. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J. Virol. 82:6200-6208.
-
(2008)
J. Virol.
, vol.82
, pp. 6200-6208
-
-
Wei, C.J.1
-
51
-
-
77958572922
-
Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin
-
Weldon, W. C., et al. 2010. Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin. PLoS One 5:e12466.
-
(2010)
PLoS One
, vol.5
-
-
Weldon, W.C.1
-
52
-
-
78651488739
-
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
-
Wrammert, J., et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181-193.
-
(2011)
J. Exp. Med.
, vol.208
, pp. 181-193
-
-
Wrammert, J.1
|